Journal article icon

Journal article

An immunocytochemical assay to detect human CFTR expression following gene transfer.

Abstract:
BACKGROUND: To assess gene therapy treatment for cystic fibrosis (CF) in clinical trials it is essential to develop robust assays that can accurately detect transgene expression in human airway epithelial cells. Our aim was to develop a reproducible immunocytochemical assay for human CFTR protein which can measure both endogenous CFTR levels and augmented CFTR expression after gene delivery. METHODS: We characterised an antibody (G449) which satisfied the criteria for use in clinical trials. We optimised our immunocytochemistry method and identified G449 dilutions at which endogenous CFTR levels were negligible in CF samples, thus enhancing detection of transgenic CFTR protein. After developing a transfection technique for brushed human nasal epithelial cells, we transfected non-CF and CF cells with a clinically relevant CpG-free plasmid encoding human CFTR. RESULTS: The optimised immunocytochemistry method gave improved discrimination between CF and non-CF samples. Transfection of a CFTR expression vector into primary nasal epithelial cells resulted in detectable RNA and protein expression. CFTR protein was present in 0.05-10% of non-CF cells and 0.02-0.8% of CF cells. CONCLUSION: We have developed a sensitive, clinically relevant immunocytochemical assay for CFTR protein and have used it to detect transgene-expressed CFTR in transfected human primary airway epithelial cells.
Publication status:
Published

Actions


Access Document


Publisher copy:
10.1016/j.mcp.2009.07.001

Authors



Journal:
Molecular and cellular probes More from this journal
Volume:
23
Issue:
6
Pages:
272-280
Publication date:
2009-12-01
DOI:
EISSN:
1096-1194
ISSN:
0890-8508


Language:
English
Keywords:
Pubs id:
pubs:116564
UUID:
uuid:09e25980-c034-4ff9-8f96-841ff1e8965f
Local pid:
pubs:116564
Source identifiers:
116564
Deposit date:
2012-12-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP